Zoetis Inc
NYSE:ZTS
Zoetis Inc
Retained Earnings
Zoetis Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zoetis Inc
NYSE:ZTS
|
Retained Earnings
$10.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
25%
|
CAGR 10-Years
39%
|
|
Johnson & Johnson
NYSE:JNJ
|
Retained Earnings
$153.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Retained Earnings
$15.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
Pfizer Inc
NYSE:PFE
|
Retained Earnings
$121.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Retained Earnings
$56.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Retained Earnings
$12.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-3%
|
See Also
What is Zoetis Inc's Retained Earnings?
Retained Earnings
10.7B
USD
Based on the financial report for Mar 31, 2024, Zoetis Inc's Retained Earnings amounts to 10.7B USD.
What is Zoetis Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
39%
Over the last year, the Retained Earnings growth was 18%. The average annual Retained Earnings growth rates for Zoetis Inc have been 21% over the past three years , 25% over the past five years , and 39% over the past ten years .